[Edaily Reporter Kim Seung-kwon ] #SAMSUNG EPIS HOLDINGS announced on the 1st that it held an opening ceremony for its China R&D (Research and Development) center on the 30th of last month. This center marks SAMSUNG EPIS HOLDINGS’ first overseas R&D hub.
The building housing the China R&D Center (Photo: SAMSUNG EPIS HOLDINGS)
The company established the center as a field-specific organization to secure a technology platform centered on antibody-drug conjugates (ADCs) and strengthen its new drug development capabilities.
SAMSUNG EPIS HOLDINGS explained that Changping District in Beijing, where the center is located, is home to the Zhongguancun Life Sciences Park—a biotechnology industrial complex—and is adjacent to Peking University and Tsinghua University, making it an ideal location for leveraging research infrastructure and human resources.
Kim Kyung-ah, President of SAMSUNG EPIS HOLDINGS, said, “Going forward, we will work closely with the Chinese biotech ecosystem and strive to continuously expand new business initiatives, such as the discovery of innovative drug candidates.”
SamsungElectronics’ Wind-Free air conditioner, first introduced in 2016, has marked its 10th anniversary. SamsungElectronics announced on the 5th that it is expanding the supply of Wind-Free air condi…
As demand for air conditioning appliances surges in Europe due to heat waves exceeding 40 degrees, domestic mid-sized and small businesses are also making a full-scale push to enter the European marke…
LG Uplus(032640)is launching the “ixi-O Roaming Call” service, which allows users to make free voice calls overseas—starting with Japan—just as they do domestically. The company plans to expand the se…
